The government’s recently unveiled structural reform plan targets savings on state drug spending of HUF 120 billion in both 2013 and 2014.

Savings could come to HUF 40 billion-60 billion at most, and that includes the increase from 12% to 18% of a special tax on sales of subsidised drugs, Szoják said.

Drugmakers accept the special tax, but think it necessary for the six-percentage-point increase to be eliminated after 2014, he added.